Second Half of 2019 Set to Be Busy for Biotech M&A

While Bristol-Myers Squibb Co.’s merger with Celgene Corporation and AbbVie Inc.’s acquisition of Allergan Plc have dominated the biotech news cycle so far this year, many industry insiders expect that the second half of 2019 will be just as busy for biotech M&A...